Identification of a Robust Five-Gene Risk Model in Prostate Cancer: A Robust Likelihood-Based Survival Analysis

Figure 8

(a, b) The ROC curve and DFS survival analysis in the TCGA test set. (c, d) The clinical correlation between the CMU5 risk score to stages and the Gleason score in the TCGA test set. (e, f) The ROC curve and DFS survival analysis in GSE21032. (g, h) The clinical correlation between the CMU5 risk score to stages and the Gleason score in GSE21032. (i, j) The ROC curve and BCR survival analysis in GSE46602. (k, l) The clinical correlation between the CMU5 risk score to stages and the Gleason score in GSE46602.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)